AML
Item
newly diagnosed or relapsed aml patients, who are scheduled to receive standard induction therapy.
boolean
C0023467 (UMLS CUI [1])
age
Item
age > 8 years and requiring no sedation.
boolean
C0001779 (UMLS CUI [1])
pregnancy
Item
patients must not be pregnant
boolean
C0032961 (UMLS CUI [1])
pregnancy
Item
women of childbearing potential must have negative serum pregnancy test performed within 7-days prior to start of study
boolean
C0032961 (UMLS CUI [1])
informed consent
Item
the subject or subject's legal guardian has the ability to understand and the willingness to sign a written informed consent and/or assent document. a signed study-specific informed consent and/or assent must be obtained prior to any study specific procedures.
boolean
C0021430 (UMLS CUI [1])
MRI
Item
patients who would be normally excluded from undergoing an mri examination - patients with a pacemaker, aneurysm clip or any other condition that would warrant avoidance of a strong magnetic field.
boolean
C0024485 (UMLS CUI [1])
allergy to gadolinium-based contrast agent
Item
patients who have known or suspected allergy to gadolinium-based contrast agent.
boolean
C0020517 (UMLS CUI [1,1])
C0016911 (UMLS CUI [1,2])
claustrophobia
Item
severe claustrophobia precluding subject from undergoing a mri
boolean
C0008909 (UMLS CUI [1])
renal function
Item
patients with acute or chronic kidney dysfunction (estimated glomerular filtration rate (egfr) < 30ml/min/1.73 m2 as calculated using the modification of diet in renal disease (mdrd) equation)
boolean
C3811844 (UMLS CUI [1])
pregnant women
Item
pregnant women are excluded from this study because of possible risk to the fetus.
boolean
C0032961 (UMLS CUI [1])